Skip to content

Author

M. d'Angelo

We have 3 of 97 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Molecular Mechanisms and Therapeutic Potential of Natural Neuroprotective Compounds in Multiple Sclerosis

Multiple Sclerosis (MS) is a chronic inflammatory disease of the Central Nervous System characterized by immune-mediated demyelination, axonal damage, and progressive neurodegeneration, which critically contributes to irreversible disability. Currently, disease-modifying therapies are effective in treating inflammatory...

Greta Paolilli Treonze, Erjola Bej, M. Catanesi et al. · 0 citations
Open access Sep 2026

rhNGF shows neuroprotective efficacy by counteracting oxidative stress and neuroinflammation in a glaucoma mouse model

It is demonstrated that rhNGF ameliorates visual acuity loss, preserves retinal thickness, sustains RGC survival, and reduces oxidative stress and neuroinflammation both in early-stage and fully developed disease.

Davide Vecchiotti, M. Di Vito Nolfi, Chiara Compagnoni et al. · 0 citations
#generative ai Review Open access Sep 2026

Molecular Engineering of Aptamers for Glioblastoma Therapy: From Simple Antagonists to AI-Driven Approaches, a Narrative Review

Computational strategies ranging from machine learning-guided sequence optimization to structure prediction and generative AI have accelerated the rational design of aptamers tailored to GBM specific challenges, enabling the development of innovative aptamer drug conjugates for targeted delivery to GBM cells.

L. Di Leandro, Martina Colasante, M. Catanesi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.